Find and Pitch Jounalists, Get Your Story Covered

Tags: corticosteroids Acute asthma vomiting hay fever

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Advances in ALL at ASH Meeting Include New Blinatumomab Data and More - 6 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 6 months ago
2	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 12 days ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - 12 days ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 15 days ago Arcellx to present positive data on multiple myeloma treatments - about 2 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL - 16 days ago New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show - 27 days ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 3 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 4 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 9 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 10 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 11 months ago Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT - 12 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - about 1 year ago
6	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Study paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants - 17 days ago
7	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL - 18 days ago FDA Approves Earlier Use of CAR-T Products for Myeloma - 9 months ago FDA Approves New Frontline Regimen for Aggressive ALL - 9 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 9 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - about 1 year ago Completely Oral Regimen Effective, Feasible in APL - about 1 year ago
8	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	FDA Investigating Blood Cancer Risk With Gene Therapy Skysona - 27 days ago Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 9 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - about 2 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 2 months ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 9 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - about 1 year ago Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood - about 1 year ago

Journalists covering acute promyelocytic leukemia